This month on Synapse
Dr Wolfgang Rehmann explains a new draft Regulation from the European Commission that aims to abolish obstacles to market access of medicinal products and medical devices which are subject to HTA in the various Member States.
Topical issues
Raman Sharma, Rhys Bufton and Lucy Sharples look at the surge in demand for campuses and science parks and discuss the benefits of clusters.
Judith Krens and Eelco Bergsma discuss the important decision on patent claim interpretation in the case Resolution Chemicals v AstraZeneca.
Alexander Kritharidis explains the European Commission's Proposal to introduce a manufacturing waiver for supplementary protection certificates.
Thanos Rammos looks at the legal challenges when using AI in healthcare from a German law perspective.
Mark Owen and Louise Popple draw attention to the new trade secrets law now in force in the UK.
